MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 145 filers reported holding MACROGENICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,864 | -12.9% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $2,140 | -25.4% | 400 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,868 | +6.9% | 400 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $2,684 | +168.4% | 400 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $1,000 | 0.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,000 | -75.0% | 400 | 0.0% | 0.00% | -66.7% |
| Q1 2022 | $4,000 | -33.3% | 400 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $6,000 | -25.0% | 400 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $8,000 | -27.3% | 400 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $11,000 | -15.4% | 400 | 0.0% | 0.01% | -20.0% |
| Q1 2021 | $13,000 | +44.4% | 400 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $9,000 | -10.0% | 400 | 0.0% | 0.01% | -11.1% |
| Q3 2020 | $10,000 | -9.1% | 400 | 0.0% | 0.01% | -25.0% |
| Q2 2020 | $11,000 | +450.0% | 400 | 0.0% | 0.01% | +500.0% |
| Q1 2020 | $2,000 | -50.0% | 400 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $4,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,215,675 | $6,503,861 | 2.01% |
| Bellevue Group AG | 9,609,913 | $51,413,035 | 0.73% |
| Frazier Life Sciences Management, L.P. | 1,803,204 | $9,647,141 | 0.58% |
| ARMISTICE CAPITAL, LLC | 5,600,000 | $29,960,000 | 0.43% |
| Delphia (USA) Inc. | 37,988 | $203,236 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 352,497 | $1,885,859 | 0.31% |
| Corton Capital Inc. | 73,678 | $394,177 | 0.18% |
| Rock Springs Capital Management LP | 1,123,096 | $6,008,564 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 129,158 | $691 | 0.07% |
| PINNACLE ASSOCIATES LTD | 709,903 | $3,797,981 | 0.07% |